| 0 |
Interleukin-5 Antagonist [EPC] |
153 |
0.2224 |
| 1 |
Antihypoglycemic Agent [EPC] |
111 |
0.0259 |
| 2 |
Sulfonamide Antibacterial [EPC] |
83 |
0.0208 |
| 3 |
beta Lactamase Inhibitor [EPC] |
23 |
0.0052 |
| 4 |
Provitamin D2 Compound [EPC] |
138 |
0.0046 |
| 5 |
Stimulant Laxative [EPC] |
43 |
0.0030 |
| 6 |
Leukotriene Receptor Antagonist [EPC] |
75 |
0.0026 |
| 7 |
Carbonic Anhydrase Inhibitor [EPC] |
30 |
0.0015 |
| 8 |
Purine Antimetabolite [EPC] |
135 |
0.0014 |
| 9 |
5-alpha Reductase Inhibitor [EPC] |
119 |
0.0012 |
| 10 |
Fluoroquinolone Antibacterial [EPC] |
150 |
0.0012 |
| 11 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
80 |
0.0008 |
| 12 |
Lymphocyte Growth Factor [EPC] |
1 |
0.0008 |
| 13 |
Azole Antifungal [EPC] |
121 |
0.0008 |
| 14 |
Thiazide Diuretic [EPC] |
114 |
0.0006 |
| 15 |
Endoglycosidase [EPC] |
1 |
0.0005 |
| 16 |
Factor Xa Inhibitor [EPC] |
130 |
0.0005 |
| 17 |
Loop Diuretic [EPC] |
148 |
0.0003 |
| 18 |
Insulin Analog [EPC] |
131 |
0.0003 |
| 19 |
Mood Stabilizer [EPC] |
57 |
0.0003 |
| 20 |
GLP-1 Receptor Agonist [EPC] |
111 |
0.0002 |
| 21 |
Methylxanthine [EPC] |
14 |
0.0002 |
| 22 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
12 |
0.0002 |
| 23 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
3 |
0.0002 |
| 24 |
Corticosteroid [EPC] |
221 |
0.0002 |
| 25 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
0.0002 |
| 26 |
HMG-CoA Reductase Inhibitor [EPC] |
62 |
0.0002 |
| 27 |
Pyridone [EPC] |
6 |
0.0001 |
| 28 |
Thymic Stromal Lymphopoietin Blocker [EPC] |
1 |
0.0001 |
| 29 |
Histamine-2 Receptor Antagonist [EPC] |
18 |
0.0001 |
| 30 |
Nonergot Dopamine Agonist [EPC] |
2 |
0.0001 |
| 31 |
Calcium [EPC] |
19 |
0.0001 |
| 32 |
Anti-IgE [EPC] |
9 |
0.0001 |
| 33 |
Vitamin D3 Analog [EPC] |
2 |
0.0001 |
| 34 |
Antimalarial [EPC] |
1 |
0.0001 |
| 35 |
Antiprotozoal [EPC] |
1 |
0.0001 |
| 36 |
Programmed Death Ligand-1 Blocker [EPC] |
2 |
0.0001 |
| 37 |
Vitamin C [EPC] |
37 |
0.0001 |
| 38 |
Copper-containing Intrauterine Device [EPC] |
4 |
0.0001 |
| 39 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
1 |
0.0001 |
| 40 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
1 |
0.0001 |
| 41 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
1 |
0.0001 |
| 42 |
Alkylating Drug [EPC] |
16 |
0.0001 |
| 43 |
Sulfonylurea [EPC] |
8 |
0.0001 |
| 44 |
Catecholamine [EPC] |
5 |
0.0001 |
| 45 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
1 |
0.0001 |
| 46 |
CD20-directed Cytolytic Antibody [EPC] |
15 |
0.0000 |
| 47 |
Dihydropyridine Calcium Channel Blocker [EPC] |
15 |
0.0000 |
| 48 |
Janus Kinase Inhibitor [EPC] |
7 |
0.0000 |
| 49 |
Antiarrhythmic [EPC] |
4 |
0.0000 |
| 50 |
Antirheumatic Agent [EPC] |
4 |
0.0000 |
| 51 |
Interleukin-6 Receptor Antagonist [EPC] |
5 |
0.0000 |
| 52 |
Oxazolidinone Antibacterial [EPC] |
1 |
0.0000 |
| 53 |
BCL-2 Inhibitor [EPC] |
2 |
0.0000 |
| 54 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 55 |
Aminosalicylate [EPC] |
3 |
0.0000 |
| 56 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
4 |
0.0000 |
| 57 |
Tetracycline-class Drug [EPC] |
2 |
0.0000 |
| 58 |
Parathyroid Hormone Analog [EPC] |
3 |
0.0000 |
| 59 |
Aromatase Inhibitor [EPC] |
3 |
0.0000 |
| 60 |
P2Y12 Platelet Inhibitor [EPC] |
3 |
0.0000 |
| 61 |
Estrogen Receptor Antagonist [EPC] |
1 |
0.0000 |
| 62 |
Histamine-1 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 63 |
Platelet Aggregation Inhibitor [EPC] |
13 |
0.0000 |
| 64 |
Insulin [EPC] |
1 |
0.0000 |
| 65 |
Prostaglandin Analog [EPC] |
2 |
0.0000 |
| 66 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 67 |
Proton Pump Inhibitor [EPC] |
12 |
0.0000 |
| 68 |
Ester Local Anesthetic [EPC] |
1 |
0.0000 |
| 69 |
Macrolide Antimicrobial [EPC] |
1 |
0.0000 |
| 70 |
Central alpha-2 Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 71 |
Phosphodiesterase 4 Inhibitor [EPC] |
3 |
0.0000 |
| 72 |
Kinase Inhibitor [EPC] |
10 |
0.0000 |
| 73 |
Complement Inhibitor [EPC] |
1 |
0.0000 |
| 74 |
Osmotic Laxative [EPC] |
5 |
0.0000 |
| 75 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
22 |
0.0000 |
| 76 |
beta-Adrenergic Blocker [EPC] |
5 |
0.0000 |
| 77 |
Estrogen [EPC] |
3 |
0.0000 |
| 78 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 79 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 80 |
Non-Standardized Chemical Allergen [EPC] |
1 |
0.0000 |
| 81 |
Aldosterone Antagonist [EPC] |
2 |
0.0000 |
| 82 |
Arteriolar Vasodilator [EPC] |
1 |
0.0000 |
| 83 |
Amide Local Anesthetic [EPC] |
1 |
0.0000 |
| 84 |
Serotonin Reuptake Inhibitor [EPC] |
1 |
0.0000 |
| 85 |
Nucleoside Metabolic Inhibitor [EPC] |
3 |
0.0000 |
| 86 |
Endothelin Receptor Antagonist [EPC] |
2 |
0.0000 |
| 87 |
Vitamin D [EPC] |
3 |
0.0000 |
| 88 |
Vitamin B12 [EPC] |
3 |
0.0000 |
| 89 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1 |
0.0000 |
| 90 |
Folate Analog Metabolic Inhibitor [EPC] |
4 |
0.0000 |
| 91 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1 |
0.0000 |
| 92 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
4 |
0.0000 |
| 93 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
1 |
0.0000 |
| 94 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 95 |
Opioid Agonist [EPC] |
2 |
0.0000 |
| 96 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 97 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 98 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 99 |
Expectorant [EPC] |
1 |
0.0000 |
| 100 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 101 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 102 |
Benzodiazepine [EPC] |
3 |
0.0000 |
| 103 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |
| 104 |
Thalidomide Analog [EPC] |
2 |
0.0000 |